middle.news

Bioxyne Surges with Record $14.1M Q1 Revenue, Eyes European Expansion

8:47am on Thursday 30th of October, 2025 AEDT Pharmaceuticals
Read Story

Bioxyne Surges with Record $14.1M Q1 Revenue, Eyes European Expansion

8:47am on Thursday 30th of October, 2025 AEDT
Key Points
  • Record quarterly revenue of A$14.1 million, up 210% year-on-year
  • Substantial investment in cannabis flower inventory to meet European demand
  • A$5.1 million purchase orders from Germany with ongoing re-orders forecasted
  • Dual listing completed on Frankfurt Stock Exchange under ticker PR8.F
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about BXN
OPEN ARTICLE